Soluble Guanylate Cyclase Activators and Stimulators in Patients with Heart Failure

被引:0
|
作者
Wei-Lin Liang
Bo Liang
机构
[1] Guangyuan Hospital of Chinese Medicine,Department of Cardiology
[2] Xinqiao Hospital,Department of Nephrology, The Key Laboratory for the Prevention and Treatment of Chronic Kidney Disease of Chongqing, Chongqing Clinical Research Center of Kidney and Urology Diseases
[3] Army Medical University (Third Military Medical University),undefined
来源
Current Cardiology Reports | 2023年 / 25卷
关键词
Heart failure; Cardiac pharmacology; Soluble guanylate cyclase activators and stimulators; Cinaciguat; Riociguat; Vericiguat; Praliciguat;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:607 / 613
页数:6
相关论文
共 50 条
  • [1] Soluble Guanylate Cyclase Activators and Stimulators in Patients with Heart Failure
    Liang, Wei-Lin
    Liang, Bo
    CURRENT CARDIOLOGY REPORTS, 2023, 25 (06) : 607 - 613
  • [2] Soluble Guanylate Cyclase Stimulators in Heart Failure
    Kansakar, Sajog
    Guragain, Ashish
    Verma, Deepak
    Sharma, Prabhat
    Dhungana, Bibek
    Bhattarai, Bidit
    Yadav, Sunil
    Gautam, Ishant
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (09)
  • [3] The Chemistry and Biology of Soluble Guanylate Cyclase Stimulators and Activators
    Follmann, Markus
    Griebenow, Nils
    Hahn, Michael G.
    Hartung, Ingo
    Mais, Franz-Josef
    Mittendorf, Joachim
    Schaefer, Martina
    Schirok, Hartmut
    Stasch, Johannes-Peter
    Stoll, Friederike
    Straub, Alexander
    ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2013, 52 (36) : 9442 - 9462
  • [4] Safety and efficacy of soluble guanylate cyclase stimulators in patients with heart failure: A systematic review and meta-analysis
    Ullah, Waqas
    Mukhtar, Maryam
    Al-Mukhtar, Aws
    Saeed, Rehan
    Boigon, Margot
    Haas, Donald
    Rame, Eduardo
    WORLD JOURNAL OF CARDIOLOGY, 2020, 12 (10): : 501 - 512
  • [5] Efficacy and safety of soluble guanylate cyclase stimulators in patients with heart failure: A systematic review and meta-analysis
    LI, Qi
    LI, Zhuqing
    LI, Tingting
    Wang, Yanxin
    Feng, Jiaxin
    Lu, Chengzhi
    PHARMAZIE, 2021, 76 (10): : 488 - 493
  • [6] Soluble Guanylate Cyclase Stimulators and Activators: Where are We and Where to Go?
    Xiao, Sijia
    Li, Qianbin
    Hu, Liqing
    Yu, Zutao
    Yang, Jie
    Chang, Qi
    Chen, Zhuo
    Hu, Gaoyun
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2019, 19 (18) : 1544 - 1557
  • [7] The efficacy and safety of soluble guanylate cyclase stimulators in patients with heart failure A systematic review and meta-analysis
    Zheng, Xiaoyu
    Zheng, Weijin
    Xiong, Bo
    Huang, Jing
    MEDICINE, 2018, 97 (41)
  • [8] Soluble guanylate cyclase stimulators and their potential use: a patent review
    Sandner, Peter
    Vakalopoulos, Alexandros
    Hahn, Michael G.
    Stasch, Johannes-Peter
    Follmann, Markus
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2021, 31 (03) : 203 - 222
  • [9] Renal effects of soluble guanylate cyclase stimulators and activators: A review of the preclinical evidence
    Stasch, Johannes-Peter
    Schlossmann, Jens
    Hocher, Berthold
    CURRENT OPINION IN PHARMACOLOGY, 2015, 21 : 95 - 104
  • [10] Soluble guanylate cyclase stimulators in patients with heart failure with reduced ejection fraction across the risk spectrum
    Butler, Javed
    Usman, Muhammad Shariq
    Anstrom, Kevin J.
    Blaustein, Robert O.
    Bonaca, Marc P.
    Ezekowitz, Justin A.
    Freitas, Cecilia
    Lam, Carolyn S. P.
    Lewis, Eldrin F.
    Lindenfeld, JoAnn
    McMullan, Ciaran J.
    Mentz, Robert J.
    O'Connor, Christopher
    Rosano, Giuseppe M. C.
    Ines Saldarriaga, Clara
    Senni, Michele
    Udelson, James
    Voors, Adriaan A.
    Zannad, Faiez
    EUROPEAN JOURNAL OF HEART FAILURE, 2022, 24 (11) : 2029 - 2036